688319

Chengdu Olymvax Biopharmaceuticals
688319

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN„6.36B
EV
CN„6.53B
Shares Outstanding
405.93M
Beta
0.56

Wall Street View

Analyst Rating
BUY
Analyst Target Price
-
P/E 2025E
133.17x
P/Revenue 2025E
10.28x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Chengdu Olymvax Biopharmaceuticals Inc.

gainify
688319

Chengdu Olymvax Biopharmaceuticals Inc.

688319

Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sale of human vaccines. It offers adsorbed tetanus vaccine; Hib conjugate vaccine; Group A streptococcus vaccine; and AC conjugate vaccine. The company also provides vacci...

Sector

Healthcare

Industry

Biotechnology

CEO

Fan, Shaowen

Employees

470

IPO Date

2021-06-08

Headquarters

No. 99 Tianxin Road, High-tech Zone, Chengdu, Sichuan Province, 611731, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.